Trump Administration's Weight-Loss Drug Deal Is Sending This Novo Nordisk Rival Surging: Momentum Score Spikes - Eli Lilly (NYSE:LLY)

A leading pharmaceutical stock that goes head-to-head against Novo Nordisk A/S (NYSE:NVO) is surging amid a potential deal with the Trump administration, which involves cutting the prices of their coveted weight-loss drugs in return for their Medicare coverage. This comes amid escalating pressure from President Donald Trump to slash the prices of popular obesity drugs, as part of the “most-favored-nation” pricing models, which seek to align U.S. drug prices with countries where they are priced the lowest. N ...